NO20065985L - System og metode for transdermal avlevering av en antikoagulant - Google Patents

System og metode for transdermal avlevering av en antikoagulant

Info

Publication number
NO20065985L
NO20065985L NO20065985A NO20065985A NO20065985L NO 20065985 L NO20065985 L NO 20065985L NO 20065985 A NO20065985 A NO 20065985A NO 20065985 A NO20065985 A NO 20065985A NO 20065985 L NO20065985 L NO 20065985L
Authority
NO
Norway
Prior art keywords
anticoagulant
transdermal delivery
derivative
benzamidine
delivery
Prior art date
Application number
NO20065985A
Other languages
English (en)
Norwegian (no)
Inventor
Joseph B Phipps
Sudeep Takhar
Rama V Padmanabhan
Janardhanan A Subramony
Original Assignee
Alza Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alza Corp filed Critical Alza Corp
Publication of NO20065985L publication Critical patent/NO20065985L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M37/00—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00—Electrotherapy; Circuits therefor
    • A61N1/18—Applying electric currents by contact electrodes
    • A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
    • A61N1/325—Applying electric currents by contact electrodes alternating or intermittent currents for iontophoresis, i.e. transfer of media in ionic state by an electromotoric force into the body
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/155—Amidines (), e.g. guanidine (H2N—C(=NH)—NH2), isourea (N=C(OH)—NH2), isothiourea (—N=C(SH)—NH2)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/455—Nicotinic acids, e.g. niacin; Derivatives thereof, e.g. esters, amides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0009—Galenical forms characterised by the drug release technique; Application systems commanded by energy involving or responsive to electricity, magnetism or acoustic waves; Galenical aspects of sonophoresis, iontophoresis, electroporation or electroosmosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00—Electrotherapy; Circuits therefor
    • A61N1/02—Details
    • A61N1/04—Electrodes
    • A61N1/0404—Electrodes for external use
    • A61N1/0408—Use-related aspects
    • A61N1/0428—Specially adapted for iontophoresis, e.g. AC, DC or including drug reservoirs
    • A61N1/0432—Anode and cathode
    • A61N1/044—Shape of the electrode
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00—Electrotherapy; Circuits therefor
    • A61N1/18—Applying electric currents by contact electrodes
    • A61N1/20—Applying electric currents by contact electrodes continuous direct currents
    • A61N1/30—Apparatus for iontophoresis, i.e. transfer of media in ionic state by an electromotoric force into the body, or cataphoresis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00—Electrotherapy; Circuits therefor
    • A61N1/02—Details
    • A61N1/04—Electrodes
    • A61N1/0404—Electrodes for external use
    • A61N1/0408—Use-related aspects
    • A61N1/0428—Specially adapted for iontophoresis, e.g. AC, DC or including drug reservoirs
    • A61N1/0448—Drug reservoir

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Radiology & Medical Imaging (AREA)
  • Dermatology (AREA)
  • Hematology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Diabetes (AREA)
  • Medical Informatics (AREA)
  • Anesthesiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Electrotherapy Devices (AREA)
  • Hydrogenated Pyridines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Media Introduction/Drainage Providing Device (AREA)
NO20065985A 2004-06-03 2006-12-22 System og metode for transdermal avlevering av en antikoagulant NO20065985L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US57690504P 2004-06-03 2004-06-03
PCT/US2005/019576 WO2005120482A1 (en) 2004-06-03 2005-06-01 System and method for transdermal delivery of an anticoagulant

Publications (1)

Publication Number Publication Date
NO20065985L true NO20065985L (no) 2007-02-28

Family

ID=35033286

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20065985A NO20065985L (no) 2004-06-03 2006-12-22 System og metode for transdermal avlevering av en antikoagulant

Country Status (18)

Country Link
US (1) US20050273047A1 (es)
EP (1) EP1758568A1 (es)
JP (1) JP2008501434A (es)
KR (1) KR20070027582A (es)
CN (1) CN1972681A (es)
AR (1) AR049434A1 (es)
AU (1) AU2005251772A1 (es)
BR (1) BRPI0511740A (es)
CA (1) CA2568625A1 (es)
IL (1) IL179675A0 (es)
MX (1) MXPA06014082A (es)
NO (1) NO20065985L (es)
NZ (1) NZ551359A (es)
PE (1) PE20060099A1 (es)
RU (1) RU2006147274A (es)
UY (1) UY28935A1 (es)
WO (1) WO2005120482A1 (es)
ZA (1) ZA200700051B (es)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2650412C (en) * 2006-04-13 2016-09-27 Nupathe, Inc. Transdermal methods and systems for the delivery of anti-migraine compounds
US20070249988A1 (en) * 2006-04-21 2007-10-25 Alza Corporation Electrotransport Delivery of Nesiritide
PL2310091T3 (pl) * 2008-05-09 2015-02-27 Wetling Ip Twig Ltd Jonizowany gaz do terapii medycznej
US8428708B1 (en) * 2012-05-21 2013-04-23 Incline Therapeutics, Inc. Self-test for analgesic product
US8428709B1 (en) 2012-06-11 2013-04-23 Incline Therapeutics, Inc. Current control for electrotransport drug delivery
EP3342452A1 (en) * 2017-01-03 2018-07-04 L'oreal Systems including association of ellagic acid and microcurrent
WO2024184792A1 (en) * 2023-03-07 2024-09-12 Pike Therapeutics Inc. Transdermal drug delivery systems for administration of a therapeutically effective amount of apixaban and other direct oral anticoagulants

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4141359A (en) * 1976-08-16 1979-02-27 University Of Utah Epidermal iontophoresis device
US4340047A (en) * 1978-10-18 1982-07-20 Robert Tapper Iontophoretic treatment apparatus
US4250878A (en) * 1978-11-22 1981-02-17 Motion Control, Inc. Non-invasive chemical species delivery apparatus and method
US4382529A (en) * 1980-12-15 1983-05-10 Drdlik Frank J Sanitary dispensing closure
US4406658A (en) * 1981-03-06 1983-09-27 Medtronic, Inc. Iontophoretic device with reversible polarity
US4456012A (en) * 1982-02-22 1984-06-26 Medtronic, Inc. Iontophoretic and electrical tissue stimulation device
US4722726A (en) * 1986-02-12 1988-02-02 Key Pharmaceuticals, Inc. Method and apparatus for iontophoretic drug delivery
US5496266A (en) * 1990-04-30 1996-03-05 Alza Corporation Device and method of iontophoretic drug delivery
US5047007A (en) * 1989-12-22 1991-09-10 Medtronic, Inc. Method and apparatus for pulsed iontophoretic drug delivery
US5637599A (en) * 1994-06-17 1997-06-10 Corvas International, Inc. Arginine mimic derivatives as enzyme inhibitors
US5983130A (en) * 1995-06-07 1999-11-09 Alza Corporation Electrotransport agent delivery method and apparatus
CA2269050A1 (en) * 1998-04-14 1999-10-14 Shigeo Yanai Method for transdermal administration of gp iib/iiia antagonist
JP2001055332A (ja) * 1999-06-07 2001-02-27 Saitama Daiichi Seiyaku Kk 芳香族アミジン誘導体類含有のイオントフォレ−シス用製剤
WO2001060448A1 (en) * 2000-02-18 2001-08-23 University Of Utah Research Foundation Methods for extracting substances using alternating current
US7137975B2 (en) * 2001-02-13 2006-11-21 Aciont, Inc. Method for increasing the battery life of an alternating current iontophoresis device using a barrier-modifying agent
US6775570B2 (en) * 2002-02-04 2004-08-10 Ceramatec, Inc. Iontophoretic treatment device
KR20060130042A (ko) 2003-11-19 2006-12-18 알자 코포레이션 전자운반에 적용되는 펩타이드로 완충된 제형 및 이의제조방법

Also Published As

Publication number Publication date
CA2568625A1 (en) 2005-12-22
EP1758568A1 (en) 2007-03-07
BRPI0511740A (pt) 2008-01-08
IL179675A0 (en) 2008-03-20
CN1972681A (zh) 2007-05-30
RU2006147274A (ru) 2008-07-20
PE20060099A1 (es) 2006-02-18
KR20070027582A (ko) 2007-03-09
JP2008501434A (ja) 2008-01-24
AR049434A1 (es) 2006-08-02
ZA200700051B (en) 2008-04-30
US20050273047A1 (en) 2005-12-08
WO2005120482A1 (en) 2005-12-22
MXPA06014082A (es) 2007-05-09
AU2005251772A1 (en) 2005-12-22
UY28935A1 (es) 2005-07-29
NZ551359A (en) 2009-03-31

Similar Documents

Publication Publication Date Title
NO20065985L (no) System og metode for transdermal avlevering av en antikoagulant
NO20075525L (no) Fremgangsmate og vaeske for syrebehandling av underjordiske formasjoner
DK1781296T3 (da) Quinazolinderivater og deres anvendelse ved behandlingen af thrombocytæmi
DK1940786T3 (da) Biphenylderivater og deres anvendelse ved behandling af hepatitis C
ATE440825T1 (de) Pyrimidin-derivate zur verwendung als modulatoren von atp-bindende kassette transportern
DK1631295T3 (da) Anvendelse af kondenserede heterocykliske forbindelser som SCCE-inhibitorer ved behandling af hudsygdomme
NO20071714L (no) Fremgangsmateer for behandling av CD30 positive lymfomer
CY1113494T1 (el) 8-ΕΤΕΡΟΑΡΥΛΟ-3-ΑΛΚΥΛΟ-1,3-ΔΙΥΔΡΟ-ΙΜΙΔΑΖΟ[4,5-c]ΚΙΝΟΛΙΝ-2-ΟΝΕΣ ΩΣ ΑΝΑΣΤΟΛΕΙΣ ΚΙΝΑΣΩΝ ΡΙ-3
DK2413142T3 (da) Fremgangsmåde til forudsigelse af NSCLC-patienters reaktion på behandling med en EGFR-TK-inhibitor
NO20081084L (no) Arylpyridiner og fremgangsmater for deres anvendelse
De Freitas et al. In vitro inactivation of the neurotoxic action of β-bungarotoxin by the marine natural product, manoalide
DE602007008870D1 (de) Verbessertes verfahren zur behandlung von cystischer fibrose
ATE483708T1 (de) Pyrrolopyridin-2-carbonsäurehydrazide als inhibitoren von glykogenphosphorylase
NO20074366L (no) Fremgangsmate for a behandle gefitmibresistent kreft
BRPI0410078A (pt) uso de efetuadores de ciclases de glutaminila e glutamato
NO20070751L (no) Inhibitorer av HCV-replifikasjon
NO20083003L (no) Anvendelse av benzofuserte heterocykliske sulfamidderivater for a senke lipider og blodglykosenivaer
CY1105962T1 (el) Υποκατεστημενα παραγωγα διοξειδιου θειαζολο-βενζοϊσοθειαζολιου, μεθοδος για την παραγωγη αυτων και η χρηση αυτων
CY1116494T1 (el) Θεραπευτικη αγωγη θρομβοεμβολικων διαταραχων με ριβαροξαβανη
ATE413392T1 (de) Kondensierte heteroyralderivate und deren verwendung als p38-kinase-inhibitoren
NO20083004L (no) Anvendelse av benzofuserte heterocykliske sulfamidderivater for behandling av stoffmisbrukavhengighet
DE602006018727D1 (de) Vorrichtung zur behandlung von langen interatrialen verzögerungen
NO20072005L (no) Nye heterocykliske amider
NO20074084L (no) Substituerte 4-fenyltetrahydroisokinoliner, fremgangsmate for fremstilling derav, deres anvendelse som medikamenter og medikamenter inneholdende disse
DE602004019674D1 (de) Verwendung von glucosidase-hemmern zur behandlung von mukoviszidose

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application